STOP‑AF trial design and results

Today we have a special guest, Dr. Jared Bunch, an international expert in atrial fibrillation and ablation, to talk about the state of atrial fibrillation and which patients benefit from early catheter ablation based on two new trials published last week in the NEJM.  We also talk about whether you should stop ACEi or ARBs in patients admitted with COVID-19, whether oral antibiotics are adequate for uncomplicated appendicitis, and whether you should target a high (90 mmHg) or low (60 mmHg) paO2 in patients with respiratory failure.

STOP-AF First trial
EARLY-AF trial
ACEi and ARBs in COVID-19
IV vs Oral Antibiotics for Appendicitis
Rifaximin after TIPS to Prevent HE
Reimagining Endocarditis Care in an Opioid Epidemic
Lower vs Higher Oxygen Targets











Music from https://filmmusic.io
"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)
License: CC BY (http://creativecommons.org/licenses/by/4.0/)

Music from Uppbeat (free for Creators!):

https://uppbeat.io/t/soundroll/dope

License code: NP8HLP5WKGKXFW2R